18P A translational project of the WSG-ADAPT-TN trial demonstrates immunomodulatory and anti-viral defense gene networks predicting pathological complete response (pCR) and survival after de-escalated neoadjuvant chemotherapy (NACT) in early triple-negative breast cancer (eTNBC)

Autor:	M. Graeser, N. Harbeck, O. Gluz, U.A. Nitz, M. Christgen, S. Kuemmel, E-M. Grischke, H. Forstbauer, M. Braun, M. Warm, J.C. Hackmann, C. Uleer, B. Aktas, R. Würstlein, E. Pelz, C. Zu Eulenburg, H. Kreipe, M. Trau, C. Stirzaker, D. Korbie
Rok vydání:	2023
Předmět:	Cancer Research Oncology
Zdroj:	ESMO Open. 8:101242
ISSN:	2059-7029
DOI:	10.1016/j.esmoop.2023.101242
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::929384fdeec6cf50e499be49f597b315 https://doi.org/10.1016/j.esmoop.2023.101242 Zobrazit plný text záznamu